Derjabo, AleksandrsČēma, IngrīdaLihacova, I.Derjabo, L.2021-06-132021-06-132013Derjabo, A, Čēma, I, Lihacova, I & Derjabo, L 2013, 980nm laser for difficult-to-treat basal cell carcinoma. in European Conference on Biomedical Optics, ECBO 2013 : Medical Laser Applications and Laser-Tissue Interactions VI. vol. 8803, 88030B, Optics InfoBase Conference Papers, Optical Society of America, European Conference on Biomedical Optics (ECBO), Munich, Germany, 12/05/13.conference97808194964612162-2701https://dspace.rsu.lv/jspui/handle/123456789/4936Begin basal cell carcinoma (BCC) is most common skin cancer over the world. There are around 20 modalities for BCC treatment. Laser surgery is uncommon option. We demonstrate our long term follow up results. Aim: To evaluate long term efficacy of a 980nm diode laser for the difficult-to-treat basal cell carcinoma. Materials and Methods: 167 patients with 173 basal cell carcinoma on the nose were treated with a 980 nm diode laser from May 1999 till May 2005 at Latvian Oncology center. All tumors were morphologically confirmed. 156 patients were followed for more than 5 years. Results: The lowest recurrence rate was observed in cases of superficial BCC, diameter<6mm; bet the highest recurrence rate was in cases of infiltrative BCC and nodular recurrent BCC. Conclusions: 980 nm diode laser is useful tool in dermatology with high long term efficacy, good acceptance by the patients and good cosmetics results.7484822enginfo:eu-repo/semantics/openAccessBasal cell carcinomaDermatologyLasersNonmelanoma skin cancerOncologySkin cancerTreatment3.2 Clinical medicine3.1. Articles or chapters in proceedings/scientific books indexed in Web of Science and/or Scopus databaseSDG 3 - Good Health and Well-being/dk/atira/pure/researchoutput/researchoutputtypes/contributiontobookanthology/conferencehttp://www.scopus.com/inward/record.url?scp=84899725006&partnerID=8YFLogxK